Ann Surg10 Sep 2025
Postoperative antibiotic prophylaxis (ppa) significantly lowers the incidence of liver-specific surgical site infections (liver-ssi) in patients undergoing simultaneous liver and colorectal resections. In a cohort of 250 patients, those receiving ppa experienced a liver-ssi rate of 11% versus 29.3% in the control group (p
Am J Gastroenterol10 Sep 2025
Patients with inflammatory bowel disease (IBD) undergoing colorectal cancer surgery face a significantly elevated risk of venous thromboembolism (VTE) compared with those without IBD. The analysis highlights VTE as a critical postoperative complication in this population, underscoring the need for heightened vigilance and tailored thromboprophylaxis…
Surg Endosc9 Sep 2025
A real-time AI-driven polyp detection system significantly improved detection rates in a multicenter trial. The system achieved a polyp detection rate of 67.18% compared to 56.92% in the control group. It particularly excelled at identifying smaller polyps (5 mm), enhancing both sensitivity and specificity. Results…
Cytoreductive Surgery & Peritoneum8 Sep 2025
Patients with colorectal cancer receiving cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS plus HIPEC) experience significantly improved quality of life (QoL) compared to those undergoing CRS alone. Results indicate a notable minimal clinically important difference (MCID) favoring the HIPEC group, with improvement often evident within…
JAMA Netw Open8 Sep 2025
Dynamic prognostic models for colorectal cancer with liver metastases significantly enhance survival predictions by integrating longitudinal laboratory markers. In a cohort of 976 patients, the most effective model outperformed static approaches, achieving area under the curve (AUC) values of 0.850 for five-year progression-free survival and…
Intestine and Lower Gastrointestinal Tract8 Sep 2025
A phase II trial aims to assess the effectiveness of indocyanine green (ICG) fluorescence-guided lymph node mapping in determining bowel resection margins for patients with colon cancer. By tailoring lymph node dissection based on individual anatomy, the approach seeks to balance extensive dissection and potential…
Surg Endosc7 Sep 2025
The robotic NICE procedure delivers superior cost-effectiveness in left-sided colorectal resections, showing a median direct cost of $9,946—well below laparoscopic ($16,389), robotic ($14,473), and open surgery ($10,427). Total costs mirror this trend, with NICE at $22,263, contrasted with $29,324 for laparoscopic, $32,908 for robotic, and…
Digital Surgery and Telemedicine7 Sep 2025
A mobile app for bowel preparation training outperformed standard instructions in ensuring compliance and quality among colonoscopy patients. In a trial of 160 adults, those using the app achieved a 94.9% adequacy rate compared to 83.8% for the control group. Compliance with dietary protocols also…
Ann Surg5 Sep 2025
Staged right colectomy (SRC) for appendiceal cancer matches overall survival outcomes compared to upfront right colectomy (URC), with SRC reducing unnecessary surgeries. Analysis of 908 patients revealed that URC was often reserved for larger, higher-grade tumors. Adjusted results show SRC demonstrates equivalent survival in elective…
Surg Endosc5 Sep 2025
Robotic surgery for rectal cancer skyrocketed from 10.1% to 45.7% of procedures from 2010 to 2021. Associated with higher odds of achieving high-quality oncologic resection, robotic methods surpassed both laparoscopic and open surgery in effectiveness. Quality surgical resections improved from 65.4% to 75.3%. Patients in…